Management of chronic hypotony following bilateral uveitis in a patient treated with pembrolizumab for cutaneous metastatic melanoma.
Reid, G Lorigan, Paul C Heimann, H Hovan, M
Reid, G
Lorigan, Paul C
Heimann, H
Hovan, M
Citations
Altmetric:
Abstract
To describe the presentation and management of severe ocular adverse events following treatment with pembrolizumab for cutaneous metastatic melanoma.
Authors
Description
Date
2018-04-19
Publisher
Collections
Keywords
Type
Article
Citation
Management of chronic hypotony following bilateral uveitis in a patient treated with pembrolizumab for cutaneous metastatic melanoma. 2018, 1-4 Ocul Immunol Inflamm